LGND (Ligand Pharmaceuticals Inc.) Stock Analysis - Community
Ligand Pharmaceuticals Inc. (LGND) is a publicly traded Healthcare sector company. As of May 21, 2026, LGND trades at $217.75 with a market cap of $4.17B and a P/E ratio of 27.80. LGND moved +4.88% today. Year to date, LGND is +13.39%; over the trailing twelve months it is +107.54%. Its 52-week range spans $93.58 to $247.38. Analyst consensus is strong buy with an average price target of $279.71. Rallies surfaces LGND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade LGND?
Rallies community data for LGND shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Rallies community data for LGND shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for LGND?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for LGND when enough community data is available.
Is LGND research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LGND. It does not provide personalized investment advice.